196 related articles for article (PubMed ID: 24408979)
1. Relationship between rate of posterior uveal melanoma flattening following plaque radiotherapy and gene expression profile class of tumor cells.
Corrêa ZM; Augsburger JJ
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):556-9. PubMed ID: 24408979
[TBL] [Abstract][Full Text] [Related]
2. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
Mruthyunjaya P; Seider MI; Stinnett S; Schefler A;
Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517
[TBL] [Abstract][Full Text] [Related]
3. Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas.
Corrêa ZM; Augsburger JJ
Am J Ophthalmol; 2016 Feb; 162():20-27.e1. PubMed ID: 26596399
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling and regression rate of irradiated uveal melanomas.
Rao RC; Khan M; Badiyan SN; Harbour JW
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):333-7. PubMed ID: 25856819
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
[TBL] [Abstract][Full Text] [Related]
6. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
Correa ZM; Huth B; Augsburger JJ
Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
[TBL] [Abstract][Full Text] [Related]
7. Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.
Seider MI; Berry DE; Schefler AC; Materin M; Stinnett S; Mruthyunjaya P;
Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):427-435. PubMed ID: 31807898
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship.
Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA
Arch Ophthalmol; 2007 Aug; 125(8):1017-24. PubMed ID: 17698747
[TBL] [Abstract][Full Text] [Related]
9. Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.
Gupta K; McCannel CA; Kamrava M; Lamb J; Almanzor RD; McCannel TA
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1371-8. PubMed ID: 26907932
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
11. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications.
Correa ZM; Augsburger JJ
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):131-5. PubMed ID: 24270974
[TBL] [Abstract][Full Text] [Related]
12. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
[TBL] [Abstract][Full Text] [Related]
13. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
[TBL] [Abstract][Full Text] [Related]
14. CORRELATION OF GENE EXPRESSION PROFILE STATUS AND AMERICAN JOINT COMMISSION ON CANCER STAGE IN UVEAL MELANOMA.
Berry DE; Schefler AC; Seider MI; Materin M; Stinnett S; Mruthyunjaya P;
Retina; 2020 Feb; 40(2):214-224. PubMed ID: 31972790
[TBL] [Abstract][Full Text] [Related]
15. Frequency and implications of discordant gene expression profile class in posterior uveal melanomas sampled by fine needle aspiration biopsy.
Augsburger JJ; Corrêa ZM; Augsburger BD
Am J Ophthalmol; 2015 Feb; 159(2):248-56. PubMed ID: 25448994
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.
Cai L; Paez-Escamilla M; Walter SD; Tarlan B; Decatur CL; Perez BM; Harbour JW
Am J Ophthalmol; 2018 Nov; 195():154-160. PubMed ID: 30092184
[TBL] [Abstract][Full Text] [Related]
17. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up.
Midena E; Bonaldi L; Parrozzani R; Radin PP; Boccassini B; Vujosevic S
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):609-14. PubMed ID: 17934749
[TBL] [Abstract][Full Text] [Related]
18. RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional Study.
Berry D; Seider M; Stinnett S; Mruthyunjaya P; Schefler AC;
Retina; 2019 Jun; 39(6):1154-1164. PubMed ID: 29578940
[TBL] [Abstract][Full Text] [Related]
19. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
[TBL] [Abstract][Full Text] [Related]
20. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]